Navigating Anticoagulation Therapy

This chapter examines the pharmacological aspects of anticoagulants like apixaban, rivaroxaban, and edoxaban, focusing on their bleeding risks and patient considerations. A clinical case study illustrates the choice of treatment for venous thromboembolism (VTE) and the complexities of managing unprovoked deep vein thrombosis (DVT). The discussion also addresses post-thrombotic syndrome and the critical role of individualized treatment strategies to enhance patient quality of life.